Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection

Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection Caplin Steriles Ltd (Caplin) has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Neostigmine Methylsulfate Injection USP in the strengths of 5 mg/10 mL (0.5 mg/mL) and 10 mg/10 mL (1 mg/mL), Caplin Point Laboratories said in a regulatory filing https://ift.tt/eA8V8J